We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Thromboembolism Prophylaxis in Surgical Patients Found Insufficient

By HospiMedica staff writers
Posted on 27 Dec 2007
A new study reports that about 85% of surgical patients do not receive recommended venous thromboembolism prophylaxis.

Researchers at the University of California at Irvine (USA) reviewed the records of 116,915 surgical patients discharged between January 2002 and December 2006 for the appropriate use of VTE prophylaxis, as defined in the seventh American College of Chest Physicians guidelines. More...
The patients were all aged 40 years and older with a hospital stay of at least six days, and without anticoagulation contraindications.

The study results found that rates of prophylaxis varied widely among surgical groups; when analyzed by type of surgery, appropriate prophylaxis was prescribed in 68% of orthopedic surgery patients, 14.9% of those undergoing vascular surgery; 13.9% of general surgery patients; 12.3% of laparoscopic surgery patients; 6.5% of gynecological surgery patients; 5.2% of urological surgery patients; and 4% of patients undergoing neurological surgery. The study was reported at the 49th annual meeting of the American Society of Hematology, held in Atlanta (GA, USA) during December 2007.

"Only 14.4% of discharged patients received appropriate thromboprophylaxis. Orthopedic surgery patients receive the highest rates, but even a third of that group does not receive treatment according to the guidelines,” concluded Dr. Alpesh Amin and colleagues. "There is a big fear of bleeding, but we have to remember we are using prophylactic dosages, not therapeutic doses of anticoagulants.”

The American College of Chest Physicians guidelines on antithrombotic and thrombolytic therapy for the prevention of venous thromboembolism are available online.


Related Links:
University of California at Irvine
VTE prophylaxis guidelines

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.